Home › Companies › Adaptive Biotechnologies Corporation › 2025-2026
Compiled from SEC Form N-PX filings. Page generated October 14, 2026.
No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Adaptive Biotechnologies Corporation has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Adaptive Biotechnologies Corporation in the interactive database Compare manager voting policies
Each item below shows how the 315 asset managers that disclosed a Adaptive Biotechnologies Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Adaptive Biotechnologies Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
99% of fund votes cast · no official result
Description as filed by funds: To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Katey Owen, PhD
The 98 asset managers below reported 50,610,991 for, 564,235 withheld, 6 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,495,475 | 0 | 6 | 10,067 | For |
| BlackRock | 6,627,973 | 0 | 0 | 0 | For |
| Fidelity | 3,795,586 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,671,643 | 0 | 0 | 0 | For |
| Invesco | 2,516,321 | 0 | 0 | 0 | For |
| Lord Abbett | 2,081,668 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,987,510 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,797,311 | 0 | 0 | 0 | For |
| ALGER FUNDS | 1,724,497 | 0 | 0 | 0 | For |
| TIAA | 1,536,717 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,145,000 | 0 | 0 | 0 | For |
| Charles Schwab | 1,131,615 | 0 | 0 | 0 | For |
| MFS | 1,072,505 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,008,596 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 774,600 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 687,260 | 0 | 0 | 0 | For |
| Principal | 555,306 | 0 | 0 | 0 | For |
| First Trust | 553,218 | 0 | 0 | 0 | For |
| Goldman Sachs | 534,382 | 0 | 0 | 0 | For |
| Hartford | 531,456 | 0 | 0 | 0 | For |
| Jackson National | 491,410 | 0 | 0 | 3,525 | For |
| Equitable | 471,234 | 0 | 0 | 0 | For |
| Brighthouse | 435,190 | 0 | 0 | 15,022 | For |
| OPTIMUM FUND TRUST | 407,197 | 0 | 0 | 0 | For |
| MassMutual | 332,936 | 0 | 0 | 0 | For |
Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.
Combines 5 wordings of this item as funds reported it.
73% of fund votes cast · no official result
Description as filed by funds: To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD
The 98 asset managers below reported 37,187,617 for, 13,987,534 withheld, 81 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,495,400 | 0 | 81 | 10,067 | For |
| BlackRock | 6,627,973 | 0 | 0 | 0 | For |
| Fidelity | 3,791,847 | 0 | 0 | 3,739 | For |
| Columbia Threadneedle | 2,671,643 | 0 | 0 | 0 | For |
| Invesco | 2,516,321 | 0 | 0 | 0 | For |
| Lord Abbett | 2,081,668 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,987,510 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,138,958 | 0 | 0 | 658,353 | Mixed |
| ALGER FUNDS | 0 | 0 | 0 | 1,724,497 | Withhold |
| TIAA | 0 | 0 | 0 | 1,536,717 | Withhold |
| HARBOR FUNDS | 0 | 0 | 0 | 1,145,000 | Withhold |
| Charles Schwab | 1,131,615 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 1,072,505 | Withhold |
| Waddell & Reed | 0 | 0 | 0 | 1,008,596 | Withhold |
| OBERWEIS FUNDS | 0 | 0 | 0 | 774,600 | Withhold |
| Aristotle Funds Series Trust | 0 | 0 | 0 | 687,260 | Withhold |
| Principal | 0 | 0 | 0 | 555,306 | Withhold |
| First Trust | 0 | 0 | 0 | 553,218 | Withhold |
| Goldman Sachs | 491,692 | 0 | 0 | 42,690 | Mixed |
| Hartford | 531,456 | 0 | 0 | 0 | For |
| Jackson National | 491,410 | 0 | 0 | 3,525 | For |
| Equitable | 393,374 | 0 | 0 | 77,860 | Mixed |
| Brighthouse | 383,022 | 0 | 0 | 67,190 | Mixed |
| OPTIMUM FUND TRUST | 158,632 | 0 | 0 | 248,565 | Mixed |
| MassMutual | 332,936 | 0 | 0 | 0 | For |
Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,505,537 | 9 | 0 | 0 | For |
| BlackRock | 6,627,973 | 0 | 0 | 0 | For |
| Fidelity | 3,795,586 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,671,643 | 0 | 0 | 0 | For |
| Invesco | 2,516,321 | 0 | 0 | 0 | For |
| Lord Abbett | 2,081,668 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,987,510 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,797,311 | 0 | 0 | 0 | For |
| ALGER FUNDS | 1,724,497 | 0 | 0 | 0 | For |
| TIAA | 1,536,717 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,145,000 | 0 | 0 | 0 | For |
| Charles Schwab | 1,131,615 | 0 | 0 | 0 | For |
| MFS | 1,072,505 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,008,596 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 774,600 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 687,260 | 0 | 0 | 0 | For |
| Principal | 555,306 | 0 | 0 | 0 | For |
| First Trust | 553,218 | 0 | 0 | 0 | For |
| Goldman Sachs | 534,382 | 0 | 0 | 0 | For |
| Hartford | 531,456 | 0 | 0 | 0 | For |
| Jackson National | 494,935 | 0 | 0 | 0 | For |
| Equitable | 471,234 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 407,197 | 0 | 0 | 0 | For |
| MassMutual | 332,936 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 311,564 | 0 | 0 | 0 | For |
Fund voting reports, all 95 managers: 50,894,688 for, 151 against, 15,022 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 29,993,708 | 0 | 0 | 0 | For |
| BlackRock | 5,437,531 | 2,375 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,994,048 | 0 | 0 | 0 | For |
| Invesco | 4,037,516 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,643,318 | 0 | 0 | 0 | For |
| Wellington | 3,113,267 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 2,872,964 | 0 | 0 | 0 | For |
| State Street | 2,774,104 | 4,618 | 0 | 0 | For |
| T. Rowe Price | 2,664,545 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 2,572,254 | 0 | 0 | Against |
| FRED ALGER MANAGEMENT, LLC | 2,109,330 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,671,182 | 0 | 0 | 0 | For |
| Amova Asset Management Co., Ltd. | 1,591,627 | 0 | 0 | 0 | For |
| Nuveen | 1,554,385 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 1,472,393 | 0 | 0 | 0 | For |
| Aristotle Atlantic Partners, LLC | 1,298,193 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,267,013 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 1,242,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,132,501 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,072,505 | 0 | 0 | 0 | For |
| Aberdeen | 1,070,627 | 0 | 0 | 0 | For |
| Vanguard | 1,064,016 | 0 | 0 | 0 | For |
| Northern Trust | 1,021,011 | 0 | 0 | 0 | For |
| Blue Water Life Science Advisors, LP | 1,010,145 | 0 | 0 | 0 | For |
| DE Shaw | 979,645 | 0 | 0 | 0 | For |
Institutional-manager reports, all 237 managers: 93,648,078 for, 3,499,859 against, 76,365 withheld, 416 abstained, 32 not voted. Showing the 25 largest; see all in the interactive database.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Brighthouse | 237,870 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,133 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,807 | 0 | 0 | 0 | For |
Fund voting reports, all 3 managers: 264,810 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ALGERT GLOBAL LLC | 109,505 | 0 | 0 | 0 | For |
| Integrated Quantitative Investments LLC | 18,150 | 0 | 0 | 0 | For |
| APG Asset Management US Inc. | 14,850 | 0 | 0 | 0 | For |
| Vinva Investment Management Ltd | 13,358 | 0 | 0 | 0 | For |
| Wilshire Advisors LLC | 5,105 | 0 | 0 | 0 | For |
| Convergence Investment Partners, LLC | 1,700 | 0 | 0 | 0 | For |
Institutional-manager reports, all 6 managers: 162,668 for.
Combines 3 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026; and
The 96 asset managers below reported 50,895,398 for, 1 against, 15,022 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,505,546 | 1 | 0 | 0 | For |
| BlackRock | 6,627,973 | 0 | 0 | 0 | For |
| Fidelity | 3,795,586 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,671,643 | 0 | 0 | 0 | For |
| Invesco | 2,516,321 | 0 | 0 | 0 | For |
| Lord Abbett | 2,081,668 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,987,510 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,797,311 | 0 | 0 | 0 | For |
| ALGER FUNDS | 1,724,497 | 0 | 0 | 0 | For |
| TIAA | 1,536,717 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,145,000 | 0 | 0 | 0 | For |
| Charles Schwab | 1,131,615 | 0 | 0 | 0 | For |
| MFS | 1,072,505 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,008,596 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 774,600 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 687,260 | 0 | 0 | 0 | For |
| Principal | 555,306 | 0 | 0 | 0 | For |
| First Trust | 553,218 | 0 | 0 | 0 | For |
| Goldman Sachs | 534,382 | 0 | 0 | 0 | For |
| Hartford | 531,456 | 0 | 0 | 0 | For |
| Jackson National | 494,935 | 0 | 0 | 0 | For |
| Equitable | 471,234 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 407,197 | 0 | 0 | 0 | For |
| MassMutual | 332,936 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 311,564 | 0 | 0 | 0 | For |
Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.
100% of fund votes cast · no official result
The 3 asset managers below reported 264,810 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Brighthouse | 237,870 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,133 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,807 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 159,697,221 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.58% |
| 2 | BlackRock | 4.15% |
| 3 | Fidelity | 2.38% |
| 4 | Columbia Threadneedle | 1.67% |
| 5 | Invesco | 1.58% |
| 6 | Lord Abbett | 1.30% |
| 7 | ARK ETF Trust | 1.24% |
| 8 | T. Rowe Price | 1.13% |
| 9 | ALGER FUNDS | 1.08% |
| 10 | TIAA | 0.96% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | VIKING GLOBAL INVESTORS LP | 18.78% |
| 2 | BlackRock | 3.41% |
| 3 | WESTFIELD CAPITAL MANAGEMENT CO LP | 3.13% |
| 4 | Invesco | 2.53% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.28% |
| 6 | Wellington | 1.95% |
| 7 | LORD, ABBETT & CO. LLC | 1.80% |
| 8 | State Street | 1.74% |
| 9 | T. Rowe Price | 1.67% |
| 10 | BNP Paribas Asset Management Holding S.A. | 1.61% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 18.78% | 13G |
| Viking Global Entities | 18.78% | DEF14A |
| BlackRock | 8.33% | 13F |
| Vanguard Subsidiaries and Divisions | 6.66% | DEF14A |
| Invesco | 2.79% | 13F |
| Wellington Management | 2.42% | 13F |
| Geode Capital | 2.28% | 13F |
| Goldman Sachs | 2.03% | 13F |
| State Street | 2.02% | 13F |
| Chad Robins | 1.96% | DEF14A |
Percentages above are of 159,697,221 shares outstanding, as reported by Adaptive Biotechnologies Corporation on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Adaptive Biotechnologies Corporation’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Adaptive Biotechnologies Corporation's shareholder meeting held June 5, 2026, in the 2025-2026 proxy season, 315 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,514 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding advisory basis, the compensation of our named executive officers… — the reporting funds and managers cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Adaptive Biotechnologies Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.